07.11.2022 - TORONTO, Nov. 07, 2022 (GLOBE NEWSWIRE) - Reunion Neuroscience Inc. (NASDAQ: REUN, TSX: REUN) ( Reunion or the “Company”), a biopharmaceutical company committed to developing innovative therapeutic solutions for underserved mental health . Seite 1